🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will consist of a screening period, 3 treatment periods and a pos...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09-20
Trial ID
NCT00536679
Treatments Being Tested
Moxifloxacin is routinely used as a probe to confirm assay sensitivity in t...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2011-07
Trial ID
NCT01642485
This study is a single-center, double-blind, randomized, placebo-controlled...
Status
Terminated
Location
Centre For Human Drug Research; Research
Start Date
2014-12-15
Trial ID
NCT02321384
This first-in-human (FiH) study consists of 2 parts: single ascending dose ...
Status
Completed
Location
Parexel - Baltimore
Start Date
2017-06-29
Trial ID
NCT03682484
Assessment of the effect of a high fat meal on the quantity in blood of a f...
Status
Completed
Location
MC Comac Medical Ltd.
Start Date
2019-01-30
Trial ID
NCT03798197
Treatments Being Tested
The objective is to conduct an RCT to evaluate the effectiveness of Licoric...
Status
Completed
Location
Conservative and Esthetic Dentistry Department-Faculty of Dentistry- Cairo University
Start Date
2020-09-01
Trial ID
NCT03763578
Treatments Being Tested
A study to investigate the safety, tolerability, pharmacokinetics, and phar...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-30
Trial ID
NCT01687309
This study is a multicenter, three-part study. Parts 1 and 2 are randomized...
Status
Completed
Location
Royal Brisbane and Women's Hospital
Start Date
2016-12-14
Trial ID
NCT02952924
Astaxanthin is a natural compound, present in many foodstuffs and available...
Status
Completed
Location
Altman Clinical and Translational Research Institute (ACTRI)
Start Date
2016-07
Trial ID
NCT03310359
Treatments Being Tested
This is a Phase 1, randomized, open label, 4-period, 6-sequence, partial cr...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2017-09-11
Trial ID
NCT03112148
Treatments Being Tested